Category Archives: The Death of Death

Monthly newsletter about life extension.

Senolytics. The death of death. October 2018. N° 115.

The search for life-prolonging interventions has often been perceived as a purely academic pursuit or as an unorthodox medical enterprise, with few or no practical results.

Yet, in fact, these studies, which explicitly aim to prolong human life, have often been a formidable, albeit rarely recognized, motivation for biomedical research and discovery. Ilia Stambler, June 2014 in The unexpected outcomes of anti-aging, rejuvenation, and life extension studies: an origin of modern therapies


Theme of the month. Products that destroy senescent cells.


There are many more cells in our body than human beings who have lived on the planet, probably around 40,000 billion. These cells reproduce by dividing, grow, die, absorb and excrete substances… In short, they are living entities that function in our body with a certain autonomy and for an extremely variable duration that can range from a few weeks (120 days for red blood cells) to a whole human life (most neurons).

As far as we know, our cells are directly descended from an organism that appeared nearly 4 billion years ago. More precisely, our cells come from the fusion, two billion years ago, between two descendants of the original organism: the primitive cells and what are today the mitochondria.

When a cell malfunctions, it is normally eliminated quickly. There are many mechanisms that lead to cell death, the best-known being apoptosis sometimes also called “cell suicide”.

But it also happens that cells that are harmful to the rest of the body continue to live. The most well-known case is cancer, an « anarchic » multiplication of cells that results in the death of the carrier individual if the body’s control mechanisms or adequate therapy do not interrupt the multiplication.

Senescent cells

Another major category of cells in poor health has been the subject of great attention in recent years by researchers working in the field of the fight against aging. These are the so-called « senescent » cells.

Substances used to destroy these cells are called senolytics. The term is based on the word « senescence« , i.e. in biology, the process of progressive degradation due to aging, and the word lysis which refers in particular to the degradation of organisms by the action of a physical, chemical or biological agent.

A senescent cell is a cell that does not function effectively for the rest of the body. It has a metabolism whose functioning has harmful consequences for the rest of the body. It accumulates and secretes pro-inflammatory factors that promote the development of age-related diseases.

The objective of the ongoing research is to destroy these cells, but of course without significant negative effects on healthy cells. This is therefore a goal quite close to that sought in the fight against cancer, where it is necessary to eliminate cancer cells without eliminating healthy cells. Products designed to destroy cancer cells are also being tested as senolytics.

Many substances have been tested in recent years on mice and some products are beginning to be tested on humans. Treatment with senolytics results in targeted apoptosis of senescent cells. It should be noted that it is not necessary to remove all senescent cells but only part of them. It is even possible that a treatment that killed all senescent cells would be counterproductive. Successful treatment reduces inflammation. On the positive side, arterial calcification is lower, reducing the risk of atherosclerosis.

To date, a positive effect has been established for mouse health levels in the short and medium term. One experiment yielded positive results with regard to the lifetime of mice, which increased by about 25%.

Tested products

Quercetin (a flavonoid) and Dasatinib reduce the « markers » of senescence in in vitro and animal studies. The anti-cancer drug Navitoclax was also examined as a senolytic.

Another flavonoid, fisetine is currently mentioned very frequently in scientific exchanges related to these new therapies, as are piperlongumine and Bcl-2 inhibitors.

Perspectives and limitations

Senolytics are currently the most frequently cited therapy in the field of research on aging. These are already-existing products, often natural (which are not very expensive to produce), whose mechanism of action is fairly well known and which could significantly extend healthy lifespan.

However, optimism about this should not be excessive. Most experiments on mice to date have not focused on longevity. The first human trials widely announced in the scientific community are only just starting. They will be double-blind and will concern elimination of senescent cells from the joints of osteoarthritis patients.

In this field as in other longevity research, greater public and private investment, faster knowledge sharing and the involvement of more researchers is desirable to enable those who wish to live in good health much longer to do so in as near a future as possible.


The good news of the month: More and more international activities concerning longevity.


There are so many activities informing researchers about human longevity that it is no longer possible to follow everything. Two conferences in Europe have recently taken place and two conferences are taking place in November:


To find out more:

 

 

 

 

 

For an international longevity station. The Death of Death. September 2018. N° 114.

People will vote with their feet once those technologies offer significant benefits. At the moment they have concerns about nature or God, but that will change if you can double somebody’s lifespan with genetic engineering (…).

People will use genetic engineering if you can ensure that your child won’t get Alzheimer’s disease (…). When it offers spare organs and the cure of aging, then of course it will be used.

Julian Savulescu bioethicist, September 2015, Source.


Theme of the month. A global mobilization for a common goal is possible


The International Space Station (ISS)

Sometimes at night we can see it with the naked eye. It is a point of light more visible than a star and which goes around our planet every 97 minutes. It passes at an altitude of 400 kilometers, far from the tiny film of atmosphere that envelops all the forms of life we know, everything we have, from our wildest dreams to our most horrible nightmares.

In this hostile environment, the United States, Russia and other nations including France have created a tiny oasis of 388 cubic meters of living space, continuously occupied since 2000. It is an object made of components so strong that they can withstand the vacuum of space and temperature variations that would kill us in a few tens of seconds, and yet so fragile that a meteorite of a few grams would be enough to destroy it.

Why are we talking about an international space station? Because the word station in French and English can mean, in addition to a place where you stop, a place where you can make scientific observations and the facilities that are located there.

The international station is one of humanity’s major collective projects. One of its objectives is prestige, but a prestige that is not directed against other groups. In this sense, this technological achievement is more collective, more united and more universal than the Apollo project of the 1960s. Because after Neil Armstrong’s « small step for man but giant leap for mankind », the first flag to be flown was not the United Nations flag but the American flag.

In the international station, most of the real work is scientific work. Unfortunately the ISS’s Space Station Biological Research Program was never started, particularly following the destruction of the space shuttle Columbia. Nevertheless, experiments are frequently carried out, some of which concern the aging process in living creatures.

Other international scientific projects

Can an international scientific project be hosted on the surface of the planet without being part of a state? Yes, certainly. First, the majority of the world’s surface does not legally belong to a state. This is the part of the oceans that is outside  territorial waters. Then there is the Antarctic continent, which does not belong to any state, under an international treaty dating from 1959. This treaty, which was particularly relevant in the context of the Cold War, was intended to be peaceful and also scientific, as precisely expressed in article 2: Freedom of scientific investigation in Antarctica and cooperation toward that end (…) shall continue.

By means of an international treaty, other territories could be removed from the jurisdiction of a state. However, this is not essential for an international terrestrial station. Many international projects have been carried out without this requirement.

CERN, the European Organization for Nuclear Research with 22 member states, has played an important role in the development of the Internet. CERN was responsible for the creation of the first « web browser ». It should be noted from the point of view of international symbolism that CERN’s buildings are located on Swiss and French territory.

UNESCO created the concept of world heritage of humanity. Science is well represented there since the first category of item on the list is what represents a masterpiece of human creative genius. However, the emphasis is more often placed on beauty than on science. There is a symbolic international aspect since inscription on the list assumes that these things also belong to « Humanity ».

The World Health Organization (of which almost all the world’s states are members) carries out, among other things, the International Classification of Diseases (ICM), the 11th revision of which is currently in progress.

The Human Brain Project aims to provide an excellent understanding of the human brain. The project, which has been controversial, includes a  medical platform. It is a work that brings together 117 institutions from 17 states, most of them from the European Union but also from Switzerland, Israel and Turkey.

An international longevity station / An Apollo project / A Manhattan project?

An international project for longevity would be a collective and united way of seeking to achieve one of humanity’s oldest dreams. It would also be a means of implementing a little-known part of the Universal Declaration of Human Rights, which states in Article 27 that Everyone has the right to (…) share in scientific progress and its benefits.

If the project starts on a non-governmental basis, it could be promoted by The International Council for Science. The ideal place would be a place where borders meet, but it could also be an international place for symbolic reasons as well as by choice of the participants.

An international station of longevity could involve:

  • The part of the « Human Brain Project » that deals with medical issues. As far as we know, there is no living species with a complex nervous system that does not die of aging. Neurodegenerative diseases are therefore at the heart of human aging mechanisms.
  • World Health Organization services and workers specifically concerned with age-related diseases.
  • An international committee (Nobel Prize winners, specialists…) to examine the most innovative proposals.
  • The best-performing scientists in the fields concerned.
  • Researchers in the field of artificial intelligence competent in health issues.
  • An international IT platform for providing data on longevity studies carried out and in progress. These are first of all human studies, but also animal studies. It is important that failures are also known.
  • An international database of human genetic data relating to health for the exclusive use of public sector (and therefore non-commercial) research. The information, coming from scientific bodies competent in public health, is collected in a secure environment and specifically designed to collect information related to the extension of healthy life expectancy.
  • An international group of doctors, nurses, health practitioners who were experimenting with new longevity therapies. These experiments involve elderly volunteers, well informed and concerned to enable those who wish to live in good health to do so for much longer.
  • A team of ethicists, economists and lawyers to examine ways to accelerate research. The aim is to implement, as soon as scientifically possible, the universal duty to assist people suffering from age-related diseases and wishing to benefit from medical progress.

The good news of the month: Longevity Festival in California


From September 20 to 23, at San Diego Raadfest was held – the world’s largest annual event for longevity activists. This year, Ray Kurzweil spoke about the progress made in terms of longevity. Among the dozens of other specialists who spoke enthusiastically, some spoke of ongoing research, others of possible financial investments.


For more information:
heales.orgsens.orglongevityalliance.org and longecity.org
Photo source

 

On the influence of one thousandth of our body mass on aging. The Death of Death. August 2018. N° 113. 

The numerous billionaires who are doing research into eternal life will soon enable us to live to 200 years old. It will then take relatively few steps before it reaches 1,000 years or before we even become immortal. I have great confidence in these billionaires and I understand their passion.

It is humiliating that life at one point simply pushes you aside. In this sense, death is an excellent technology that allows nature to thrive. After a person has served a purpose, a new one replaces it. But sooner or later, every technology will become obsolete. In the case of our mortality, it will take one or two major breakthroughs.

Manu Joseph, Indian writer and journalist. 17 August 2018, translated.


Theme of the month. On the role of a few very small organs in aging.


Each human being is a universe made up of hundreds of billions of cells but also of bacteria. Each of these entities is in turn a set of structures and corpuscles that we only partially understand.

All of the structures, organs, corpuscles etc.  which see to the functioning of our organism are of an extraordinary complexity. The links between the organs, the rhythms, the contacts with the outside, are almost always multidirectional. A glass of water that we drink, a feeling that we feel, an hour more and less sleep… everything has physiological effects.

We know more about our bodies than ever before. At the same time, a vast amount remains to be discovered. There is that which we do not understand. There is what which we still do not even know exists. And there are probably a lot of things we wrongly think we know. For centuries, tobacco was used as a medicinal plant and bleeding was one of the main remedies.

Among the hundreds of organs in our body, some very small ones are essential to our harmonious functioning. This letter discusses the role in longevity of the thymus, thyroid, hypothalamus, pituitary gland and hippocampus, five organs that together represent about one thousandth the weight of an ordinary adult.

Thymus

The thymus is at the centre of the immune system. It is a very small organ located close to the heart. Its maximum weight (about thirty grams) is reached at the end of adolescence.

The thymus specializes in the maturation of T lymphocytes  (T for thymus). Its role is to detect cells infected with a virus, or cancer cells, and destroy them.

One of the major aspects of aging is the decrease in the effectiveness of the immune system, which manifests itself in two ways:

  • Infected or sick cells that should be destroyed are no longer destroyed
  • Healthy cells are attacked (auto-immune diseases)

Allowing the entire immune system to function with reduced senescence is a major challenge. However, the thymus loses its volume throughout our life (the medical term is involution) until sometimes it disappears by being totally replaced by ordinary fat cells. As we age, we become more and more susceptible to contagious diseases.

If we could regenerate the thymus, we could help elderly people to fight infections more effectively. Scientists, including biogerontologist Greg Fahy, are studying ways to achieve this.

Thyroid

The thyroid is a gland located in the neck. It weighs about thirty grams and produces certain hormones (thyroid hormones). These hormones are vital and have an influence on all of the rhythms of the body: cardiovascular, growth and metabolic.

An important aspect of aging is the decrease in the production of certain hormones. Many doctors have long prescribed hormones to combat aspects of aging. Unfortunately, no strong influence seems to have been demonstrated in terms of longevity merely due to taking hormones. As far as the thyroid is concerned, curiously it is reduced activity of this gland that is associated with a higher life expectancy.

The hypothalamus and the pituitary gland

The hypothalamus is a very small part of the brain located at its base. It weighs only about 4 grams but plays a decisive role in many physiological functions including hormone release and regulating body temperature. It is connected to the pituitary gland, an even smaller organ weighing less than a gram, that produces many hormones, the best known of which is growth hormone.

The influence on longevity of these organs in the event of malfunction is clear and rapid. However, as is almost always the case in longevity research, the results of a modification aiming at an improvement are mixed. Growth hormone has been – and still is – presented as an « anti-aging » product but no studies to date have demonstrated efficacy in terms of average or maximum life span in humans. The effect could even be the opposite.

The hippocampus

The hippocampus is a part of the human brain (and mammals in general) that has a shape similar to a sea horse (Latin name hippocampus). We have one hippocampus per hemisphere, both together weighing only a few grams. The hippocampus plays a central role in memory and orientation in space. In Alzheimer’s disease, the effects of the degradation of this organ are usually felt in the hippocampus before affecting the rest of the brain. This is marked by a loss of short-term memory and sense of direction.

We know a lot about the development mechanisms of neurodegenerative diseases and particularly Alzheimer’s disease, but we are still very far from a cure. We know that the hippocampus tends to lose volume with age, especially in sick people. But to date, unfortunately, for this organ as for the rest of the brain, no specific effective treatment exists.

And more generally

As discussed at the beginning of this letter, our body is a network of interdependencies of a complexity that no computer environment in the world can yet simulate, even in an approximate way. But the role of certain parts is fundamental, acting in particular on the speed of aging. Knowing these organs better will be useful in advancing our understanding of the mechanisms of aging.

Please note, however, that to enable women and men who wish it to live (much) longer in good health, it is not necessary to fully understand the mechanisms of aging. To draw a parallel, even today, we don’t fully understand how anesthesia works.

Even if understanding the body with its components and its functioning will be insufficient, it is indispensable. What is also indispensable is to seek to find out, in particular through experimentation with informed volunteers, what we can do to reduce the suffering and illness caused by senescence.


News of the month. No supercentenarian over 115 years of age alive but human cells have been regenerated


On July 22, 2018, Ms. Chiyo Miyako, a Japanese woman who was the oldest member of humanity, died aged 117. She is succeeded by another Japanese citizen, Kane Tanaka, but she is only 115 years old. And according to the Gerontology Research Group, there are only 6 people in the world « confirmed » as being more than 113 years old.

But even if this does not yet translate into longer maximum lifetimes, research is progressing. The human body ages, partly because our cells age. British researchers at the University of Exeter are trying to reverse cell senescence. According to a published scientific article, they succeeded in the laboratory, by using resveratrol-based molecules, in reversing part of the aging of certain human cells (fibroblasts).

Note that a few years ago, in France, Professor Jean-Marc Lemaitre and his team had already succeeded in turning cells from centenarian people into stem cells.


For more information:

 

 

 

Longevity and generosity. The death of death. July 2018. N° 112.

Some people say, “Oh, you shouldn’t do enhancement” but the thing is we do enhancement all the time to some extent, all aging reversal is enhancement. Vaccines are enhancement… I think I’m just now getting up to speed after 63 years of education. Aging reversal is something that will buy me and many of my colleagues a lot more time to make many more contributions, so you might consider that a meta-level contribution, if we can pull that off. World-renowned Harvard University biology researcher George Church (source).


Theme of the month. How to contribute financially to research for a much longer healthy life


Introduction

If you have considerable financial means you can afford medical care more easily than less well-off citizens. But whether you are rich or not, with a good « genetic capital » or not, whatever your precautions and your anti-aging clinic visits, in the current state of knowledge your chances are low of living more than 100 years if you are a woman and beyond 95 years if you are of the weaker sex for longevity. And whatever happens, you will not live past 122 years for a woman et 116 years for a man.
To go further will require complex and costly research. If informed citizens pay money to support this research, it will be positive in a direct way by funding the research. It will also be positive in that it will show the growing interest in these issues.

What could you do about it?

Moderate financial support

If your financial means are limited or if you do not wish to make large donations, your action can still have an impact. If every adult citizen of the world donated €1.50 per month this would make an annual investment for longevity of nearly €100 billion. That would be more than the wealth of Bill Gates, the richest person in the world.

But we are far from having a convinced world population. You could give the price of one coffee a day (about €500 per year) or at least the price of one coffee a week (€100 per year).

For small-scale support it makes sense to focus on one goal. The organization that is best known and most active for longevity is SENS (Strategies for Engineering Negligible Senescence). Aubrey de Grey, the head of this organization, is the world’s best-known biogerontologist. His tireless commitment to this cause led him to give most of a large family inheritance (upon his mother’s death) to fund research.

The Forever Healthy Foundation is another non-profit organisation, this time from the German-speaking world, founded by Michael Greve. It works in partnership with SENS.

Small streams make large rivers but for donations to « rain down », encouragement is needed. If your investments are moderate you can make them visible by countless means: virtual of course (Twitter, Facebook…) but also by contact with your family. There is also an organization that collects donations for longevity and communicates widely about donations. This is the Life Extension Advocacy Foundation (LEAF).

You can also make donations to organizations that are more involved in communication and exchange of ideas on this subject: at European level Heales (Healthy Life Extension Society) and at international level Longecity and the International Longevity Alliance.

Substantial financial support

If you wish to donate a larger sum (€10,000+) you can certainly ask that the amount be allocated to a research project which seems especially interesting to you. This can even include helping profit-making organizations, because the number of ‘charities’ for longevity research is unfortunately limited. In the French-speaking world, Elvesys is doing some very promising research and also publishes a lot of information about longevity.

In the case of a specific project, a cautious approach is to seek advice first (of course) from the people working on the project in question, but also from one or more longevity specialists who do not have a direct interest in the area concerned.

Major financial support.

A researcher’s work is expensive. €100,000 a year for the financing of a researcher (remuneration plus necessary equipment).

You might decide to invest money in longevity rather than giving it away. A British billionaire, Jim Mellon, recently wrote a book on this subject. This is outside the scope of this letter.

If you have capital to donate representing months, years, decades or centuries of work by a researcher, consider that every day more women and men die from age-related diseases than there were deaths in Hiroshima in the 24 hours following the bombardment. An effective therapy advanced one week by your financial intervention would save nearly a million lives. If you think we have a good chance of doing so, you might even consider it an ethical duty to intervene.  

If you make public your donation, the impact will be all the greater the larger it is and the more you are personally disinterested.

Charity begins at home

More selfishly, consider, if you are over 40, that even if you are a multi-billionaire your remaining life expectancy (less than 50 years) is less than that of a baby being born today in the poorest country in the world. Over the next three to four decades, therapies for aging can change dramatically. But they could also remain fairly stable. You can help shape humanity’s evolution… or not.

With significant capital, moreover, it will most probably be possible to be associated with the conduct of research or even the use of new therapies.

Whether you are rich and powerful or weak and poor our time, despite its imperfections, is the best time in the history of humanity to be alive. And you can contribute financially so that tomorrow will be better especially for the older people, that is to say the weakest among us.


The good news of the month:
an international short film competition for longevity
a WHO code for aging


Until September 15 you can take part in the Longevity Film Competition, an international short film competition created to help raise awareness of the importance of fighting age-related diseases. The first prize is 10,000 dollars. An international jury composed of filmmakers, scientists, entrepreneurs and experts in the fields of regenerative medicine, aging and longevity will decide between the candidates.

The international classification of diseases (ICD) is the international standard for clinical diagnosis, epidemiology and health management. As part of the preparation of the 11th version (CIM-11), a code (XT9T) « relating to aging » was introduced. This code allows for clinical evaluation and approval – and for insurance companies to provide cover for – therapies targeting this disease.


For more general information, see in particular: heales.orgsens.orglongevityalliance.org and longecity.org

 

The Gompertz curve and aging. The death of death. June 2018. N° 111.

Expressions such as “healthy aging” and “aging gracefully” signify that (…) you’re relatively healthy and/or the cosmetic signs of aging aren’t as pronounced as they could be. (…)

This choice of words is rather problematic, especially now that the dawn of rejuvenation is visible on the horizon. The terms “healthy aging” and “successful aging” really are sharp contradictions in terms. If you read the scientific literature on aging, most if not all papers giving general introductions to the phenomenon define it as a chronic process of damage accumulation or a progressive decline in health and functionality. If we try to replace these definitions in the two expressions above, the results are frankly hilarious: “a healthy chronic process of damage accumulation” and “a successful progressive decline in health and functionality”. What’s that even supposed to mean?

Nicola Bagalà, mathematician, artist and life extensionist from the Life Extension Advocacy Foundation (LEAF) in the article Getting sick in a healthy way.


Theme of the month. The periodic doubling of the risk of dying


Exponential growth in the risk of dying in humans

William Makeham was a British actuary and mathematician who lived in the 19th century. He was the first to discover that, for adults, the probability of dying from disease doubled at regular intervals. Represented by a line on a diagram, the risk of death thus follows an exponential upward curve, gentle at first and then increasingly steep.

This « law » of human mortality is called the Gompertz–Makeham model.

Doubling of mortality occurs approximately every 8 years. In other words, a 70-year-old is about twice as likely to die in their seventy-first year as a 62-year-old is likely to die in their sixty-third year.

In 2018, we live much longer on average than in the 19th century. It seems, however, that Gompertz-Makeham’s law is highly independent of medical progress. When life expectancy increases, mortality curves follow broadly the same logic as before but starting at a greater age.

Understanding this mechanism has been and is still useful for researchers and entrepreneurs who calculate the multiple economic factors influenced by average lifespan. This ranges from insurance premiums to the financing of social security and demographic prospects. On the other hand, the general public is unaware of this, seeing aging as a rather random phenomenon.

Exponential increase in the risk of death in other animals

For animals in captivity (or cultivated plants) therefore without risk of predation, the pattern of the risk of death with age varies. Three broad categories can be distinguished:

  • Animal species that have a fairly precise life span. They are often in good health until reproductive age or until the end of the summer and then die quickly. This is the rule for many insect species and for so-called annual plants. The best-known vertebrate in this regard is probably the salmon, but there is also a species of marsupial, the antechinus in which the male dies very quickly after reproduction.
  • Living species, especially plants, that have no known senescence mechanism or that do not have exponential growth in the probability of dying with age. This applies to tree species, including the redwood, as well as lobsters and some bivalves.
  • Species that, like humans, have an exponential growth in the probability of death.

For species with an exponential increase in the risk of dying, the mortality doubling period will almost always be shorter than in humans since very few animal species have a maximum life span as long as ours.

Generally, anti-aging experiments involve mice or rats. By knowing the mortality tables of these rodents, it is easier to evaluate the effectiveness of a treatment in fighting senescence by comparing the death curves with or without the new therapy without having to wait for the death of all the animals.

Also, given the increasing probability of death with age, it is more useful and easier to examine older animals than younger ones. If a new product or therapy is effective (i.e. increases lifespan), a difference in mortality will appear more rapidly when comparing groups of older mice (more fragile and dying more often) than when comparing groups of young mice.

However, there is a financial barrier to research on older animals: laboratory animals cost more if they are older (because they have to be raised to the right age).

The exponential growth in the risk of death is general for an individual but also specific for most conditions.

Gompertz-Makeham’s law is little known. What is even less known is that this law also applies, with nuances, to most causes of mortality. The diagram above shows the probability of death by age for most causes of mortality on an exponential scale. Whether it is the risk of dying from cancer, cardiovascular disease or neurodegenerative disease, in each case the probability of death increases with age. Even for infectious diseases, the probability increases exponentially. No one thinks that a simple bout of flu is an age-related illness and yet the risk of dying from it is much higher in an elderly person than in a young person.

The Gompertz curve is explained, of course, by all the aging mechanisms that accumulate and ultimately cause death. When therapies can be studied and then put through double blind tests under rigorous scientific conditions, it is conceivable that the exponential progression will be slowed down and indeed perhaps one day will cease to exist.


News of the month : Right to try in the USA for people suffering from incurable diseases


New legislation has just been adopted at federal level in the United States under the name of Right to try. It allows, under certain conditions, people with incurable diseases to try innovative therapies. Some say that this legislation will save patients’ lives thanks to medical advances without having to wait for a bureaucratic approval procedure.

Unfortunately the new legislation in question is still very limited, particularly as regards information on new therapies. Pharmaceutical companies are not obliged to deliver care and have no obligation to publish the results of new treatments in terms of patient survival.

More rigour therefore remains to be obtained in terms of transparency, but awareness of the importance of accelerating medical research for citizens’ health is progressing.


For more information:

Source of the illustrations : simple curve in the first illustration : awesci.com/gompertz-law-dreadful-law-death, complex curves in the second illustration supplied by LongLongLife.

The side effects of a much longer life in good health. The death of death. May 2018. N° 110. 

 

The financing difficulties (in the fight for longevity) are due to the desperation that almost all people have to put ageing out of their minds and pretend that it is some kind of blessing in disguise, so that they can get on with their miserably short lives without being preoccupied by the terrible thing that awaits them. This attitude is psychologically understandable but morally inexcusable… Aubrey de Grey, the world’s best-known and most active biogerontologist, Varsity (Cambridge University online journal). Interview, 27 April 2018.


Theme of the month: The consequences of a world with negligible senescence)


This letter concerns the most likely and desirable social, economic and cultural consequences of a much longer healthy life. It is based on the hypothesis that a therapy that makes senescence mechanisms negligible is accessible at a modest price (a bit like the price of vaccines or an appendix operation today). It is also assumed that the technological and cultural environment is similar to ours. If this letter were a literary short story, it would be alternate history (what would the world be like if we didn’t age today) rather than prospective, future history (what will the world be like if we don’t age in 30 years’ time).

This letter is deliberately positioned in expectation of positive developments. However a positive collective use of medical and social advances is not guaranteed. A society of ‘amortals’ and servile mortals is conceivable. Vaccination could have been used to protect soldiers invading artificially contaminated countries, organ transplantation could be done by executing poor people to give a better life to the rich, blood transfusion could be reserved for deserving workers to ‘boost’ their ability to work. However, all this is unlikely in a contemporary world where there is increasing respect for human life.

Here are the possible side effects of amortality in a world, after all, not so different from ours:

Unintentional inequalities in the face of death are rare, longevity is accepted by religious representatives, but there are « Amish of longevity »

Some imagine that a society where it is possible not to age would be divided into two camps: the moderns and traditionals. In fact nothing obliges the « traditionals » today to have electricity, running water, central heating, internet access and a smartphone. All this is radically « unnatural » and all this is very useful and has become or is becoming universally used. Nor do « traditional » people have to see a doctor when they are seriously ill, yet almost everyone does. There is no reason why the use of longevity therapy should have to be obligatory. In a world where longevity therapies are available, it is likely that they will be used by almost everyone with that slight sense of vertigo that we sometimes feel when we see a historical documentary or read a book from the past where everything was so different and, in many ways, atrocious.

Religious representatives would not oppose it any more than they have opposed vaccinations, painless childbirth, organ donation etc. once it has become widespread. Of course, none of this is explicitly provided for in the sacred books, but none of it is explicitly prohibited either. The sacred books speak of the obligation of dying of old age, but what if it no longer existed? These books also say that the slave must obey his master. When death from old age no longer exists, when slavery no longer exists, we no longer need to submit to it. Equality and longevity are concepts for which great religions can easily find theological bases.

However, there would probably be a few people who would like to continue to age. In societies with a democratic tradition, this diversity is not only manageable, it is desirable. The Amish of the eastern United States teach us many things about a population reducing access to certain technologies; people who wish to age when it is avoidable will teach us the social, health and moral consequences of an otherwise lost world.

Much more investment in personal health and safety

A human life has a price, even if that has to be couched in careful language so as not to shock. There is even a technical term which is much-used for calculating it, known as QALYs for « quality-adjusted life years ». It refers to the number of years a person has left to life, weighted according to quality of life. If aging becomes negligible, the financial value of a human life is multiplied by a factor of 10 or more in a country like France (as compared to now). On the one hand, life expectancy would no longer be measured in decades but in centuries; on the other hand, the majority of incapacitating diseases (in particular Alzheimer’s disease) would disappear or become exceptional.

This means, in purely economic terms, that a human life is more valuable and that financial efforts to save lives are much more « profitable » economically. In other words, more money and energy would be invested to prevent road deaths, to limit accidents at work and domestic accidents and to prevent deaths in natural disasters because life would be more precious than ever. Some even argue that life will be too precious, that individuals would no longer dare take any risk. It is not unimaginable that some will feel restricted by safety measures, just as many citizens in the past have rejected speed limits on the road or fire-prevention measures. But the priority is to protect the community from the actions of a minority in a world in which technological progress is a source of social progress but also entails considerable risks.

A lot more financing

This letter assumes that longevity therapy will be inexpensive. The reasons for this are that a therapy applied to billions of people has a very low marginal cost per individual and that medical therapies of any kind are much more expensive to discover than to apply. Research is expensive, medical infrastructure is expensive, pharmaceutical companies and some medical professions are highly paid, but the products and therapies themselves have a very reasonable cost.

Spending would be low while at the same time healthcare cost savings would be immense. Indeed, until now, the bulk of healthcare costs have been concentrated on treatments due to age-related diseases during the last years of life. In the hypothesis envisaged, this will only concern a small number of people. The savings will not only include healthcare as such but also a radical reduction in costs for retirement homes, support for the elderly, measures enabling families to care for suffering relatives etc.

Some are concerned about a possible « ban on choosing to age » because of economic costs. In fact, given the considerable savings that would be made, the financial means freed up for those who would choose to continue aging would be considerable. These financial resources, in an otherwise unchanged world, would also free up millions of people who could devote themselves to other socially useful tasks such as assisting people in psychological difficulty. It would also allow for the organization of a real “culture of leisure” where citizens could have a good time with their “young” parents rather than feeling guilty about “abandoning” them during the holidays.

Life more precious psychologically

To die is nothing, but to see others die, oh! to see people die… could be lines from a song by Jacques Brel. The human being is the only living being aware of the inevitability of his or her end. We are confronted with our own finitude and that of all those we love, our children, our parents, our loved ones. We can only survive this situation psychologically by reserving for ourselves spaces of indifference. But we do not want or cannot let this indifference be seen by social convention or so as not to cause suffering to relatives.

A much longer life would make this schizophrenic attitude avoidable or much rarer. The longer we live, the longer our loved-ones will live, the more we will be able to love and help each other. To better understand this more pleasant world, let us remember how much infants and young children were much less « precious » than today. It is not because our forefathers were unable to love their children that they became much less attached to them, but it is because the children very often did not survive. To become attached to them was to suffer too much. Today we love and respect each other much more than yesterday, but not enough. A world without senescence would be a world where we would be more human, more empathetic, more compassionate, more easily and for longer.

Calmer, more fulfilling, less stressful life

The human being lives at the same time as if he or she was going to live forever and as if he or she was very soon going to die. Our behavior is often illogical. Sometimes we burn the candle at both ends, sometimes we save as if we were going to live for centuries. A life without senescence will be calmer, more fulfilled and without emergencies due to our end and that of others. Some worry that couples will no longer be « for life » because life will be much longer. It still seems preferable to see a couple interrupted by a break-up than by the death of a partner, considering moreover that, already today, most couples do not last « for life ».

Children more wanted and less numerous

We already know that a much longer life is closely linked to a reduction in the number of children per woman. Therapy against senescence would allow women fertility without time limit. This would most likely mean that women would have far fewer children in the short to medium term.

It would also mean that children would be more wanted and loved than ever before in human history. More loved because they are fewer, more loved because we will know we can live together longer.

Conclusion

Living better, longer and in good health: who would be against it? Almost nobody. Yet at the thought that we could live much better, much longer and much healthier lives, many worry. Why? Not because it is « unnatural », « evil », « immoral », but because the hope of a better future makes the reality of the present difficult to bear. Yet we must accept and enjoy the present until we can change it. And we must improve the human community, where possible, as thousands of generations have done before us.


Good news of the month: European research budget is increasing and European Commissioner Carlos Moedas announces plans for « moonshot » health projects


Positive news in the area of research is multiplying, particularly in the area of health and involving public money.

The European Commission has announced a research budget reaching 100 billion euros for the period 2021-2027, which is a major increase.

Carlos Moedas, European Commissioner for Research, Innovation and Science, pointed out in particular the need for exciting « moonshot » type projects to spark Europeans’ imagination about the future and encourage them to feel inspired rather than pessimistic. He gave Euronews as an example the will to cure Alzheimer’s disease or to turn cancer into a chronic disease. At the Horasis Global Meeting in early May, he spoke about how we have doubled life expectancy over the past 100 years and said it is « incredibly exciting » to think of the next exciting innovation that will transform our lives.


For more information

Is your number always going to be up beyond age 115? The death of death. April 2018. N° 109. 

« For men of science death is not an inevitable destiny, but merely a technical problem… Our best minds are not wasting their time trying to give meaning to death… We’re now at the point where we can be frank about it. The leading project of the scientific revolution is to give humankind eternal life. Even if killing death seems a distant goal we have already achieved things that were inconceivable a few centuries ago… A few serious scholars suggest that by 2050 some humans will become a-mortal… in the absence of serious trauma their lives could be extended indefinitely… » Sapiens: A Brief History of Humankind, page 298. 2014. Yubal Noah Harari.


Theme of the month. The mystery of the supercentenarians deepens.


The current situation

Average life expectancy continues to increase even in countries where men and women live longer than 80 years. There are more octogenarians, nonagenarians and centenarians than ever before in human history, both in absolute numbers and in percentages.

However, the maximum life expectancy is not going up. The longest-lived person in the history of humanity is Jeanne Calment. She died aged 122 in 1997. This April the oldest person in the world, who was 111, passed away. Given that the oldest woman alive today is ‘only’ 116 years old, this means that it will still take at least seven years before the longest-ever lifespan is exceeded.

More generally, the number of supercentenarians, i.e. people aged 110 and over, remains extremely low and the average survival time of these exceptional people is very short; less than a year. The likelihood of someone aged 100 attaining 110 seems today even less than at the end of the 20th century.

The fact that the average lifespan is increasing but the maximum lifespan is stagnating means that increasingly we are seeing a ‘rectangularisation’ of the death curves, which are becoming concentrated in a fairly narrow age range. For women in France, the age at the end of life will, in most cases, be 85 to 100. For men, it will be three or four years earlier, after 80 up to around age 95. It is remarkable that this concentration of the age of death is global. It is in poor countries where average life expectancy is short that life expectancy growth is fastest (especially in sub-Saharan African countries) and it is in the richest countries where life expectancy is longer that growth is slowest with signs of stagnation. From this point of view, the world has never been more egalitarian.

March 2013. A first letter on this theme, entitled The mystery of the supercentenarians was published. Five years later, a scientific and media controversy breaks out following the publication in 2016 of an article in Nature relating to an observed limit to life expectancy of around 115 years. That article aims to establish that there is an extreme age limit to lifespan around that age. The idea was contested by certain longevists and appreciated by certain bioconservatives. In both cases the commentators generally fail to cite a short but important phrase in the article which clarifies that this limit seems to be absolute in the absence of medical advances.

How is it that all the medical advances of this century and the end of the last century, all the technological accelerations, are failing to extend the lifespan of our oldest fellow citizens? We analyze the genetic heritage of millions of people and understand more and more of the human being’s complexity, we recover more and more often from cancer, mortality from cardiovascular diseases is decreasing… but to be a supercentenarian today is something as exceptional as being a centenarian in ancient Greece or the earliest Chinese empires. Why?

Possible explanations not linked to the state of health as such

Until a certain age, many people seek to be perceived as young. But for the oldest people, it is often the opposite, they pretend to be older than they are.

Claims about very long lives of 130 years and more are almost certainly false. In fact, as the risk of mortality at age 110 is at least 50% per year statistically there is a less than a one in a million chance of a 110-year-old reaching age 130. But there are only a few hundred people aged 110 and over in the world.

It is almost certain that most of the so-called supercentenarians of the past were younger people who “aged themselves” so as to seem wiser or so as to benefit from material advantages (to escape conscription, receive a pension etc). It should also be noted that extreme claims often concern men. However more than 80% of centenarians are women and the oldest man in the world today is only 112.

Extreme longevity was therefore exaggerated in the past, but this does not explain the stagnation observed by the Gerontology Research Group (GRG). For the past thirty years or so, this group has been counting supercentenarians by checking proof of dates of birth. ‘Made up’ claims are therefore ruled out. What is more, all other things being equal, logically we should find a more than proportional growth in the number of supercentenarians, given that the administration of 110 years ago (attesting to living supercentenarians today) was generally better than that of 130 years ago (attesting to supercentenarians living 20 years ago). It is not the case, even if the average age of death of ‘verified’ supercentenarians is slowly increasing.

Some speak of a ‘statistical accident’. Jeanne Calment, they say, was just an isolated phenomenon and supercentenarians are not numerous enough to be able to draw conclusions. This explanation becomes less and less defensible as the number of centenarians grows while the number of supercentenarians stagnates. Thus, in France there were 8,063 centenarians in 2000 and 16,255 in 2018. The number of supercentenarians verified by the Ecole Polytechnique’s Management Research Centre went from eight in 2000 to only three in 2014 (the real number of supercentenarians is probably higher).

Explanations related to health conditions

That which does not kill you only makes you stronger is a saying that is sometimes heard in the fields of psychology and health. If this idea is true then, it is conceivable that people becoming supercentenarians in recent decades have been less subjected to difficult episodes strengthening them and therefore are less resistant to extreme old age.

On the other hand, it is conceivable that the people who died in the last century were privileged for all or part of their lives compared to the supercentenarians born later. This could have a positive impact on their lifespan.

In both cases, it must first be established which chronologically specific circumstances are to be taken into account, bearing in mind that it cannot relate to a geographically limited event since the ‘drying up’ phenomenon occurs from Japan to France via the USA and Russia.

As far as the hypothesis of reinforcement by difficult circumstances is concerned, it seems rather that very hard life conditions well before reaching old age decrease life expectancy rather than increasing it.

As far as the hypothesis of circumstances having deteriorated in relation to the past is concerned, it seems improbable because the 20th century as a whole was much more characterized by progression than by regression. But there is one area where change has included important negative aspects, and that is pollution, particularly air pollution, and especially fine particles.

Pollution has not appeared recently, very far from it. But many sources of pollution, including fine particles and nuclear radiation, are newer and are present around the world to varying degrees.

If these kinds of pollution are harmful to health in a cumulative way over a lifetime, this could explain the phenomenon in question.

This very worrying line of reasoning has at least two weaknesses:

  • It does not explain how pollution would have a very negative impact on supercentenarians but not on centenarians.
  • It does not seem to be confirmed by examining the origin of supercentenarian populations. Japan and France, for example, which have many supercentenarians, are not particularly lacking in air pollution.

An unknown disease?

There remains the hypothesis of a condition especially affecting the very elderly. In support of this concept, it should be noted that many centenarians and supercentenarians die from a little-known condition, senile transthyretin amyloidosis, a disease characterized by the accumulation of a certain type of protein (transthyretin) in the heart. Here too, it remains to be explained:

  • Why would this disease have more lethal consequences today than yesterday?
  • Why this disease would have greater negative consequences for those reaching the oldest ages but less for the ‘mere’ centenarians?

The solution to the mystery lies with the researchers

The temporary conclusion of this letter is that the scientific community does not yet know why the number and maximum age of supercentenarians are stagnating or even decreasing.

Imagine if the buildings of our cities deteriorated less and less quickly during a century then started to deteriorate more quickly – that would probably have a greater impact on public opinion than the situation described in this letter.

It is true that a well-maintained 100, 120 or 150-year-old building may be like new.

What we can be almost certain of is that it will take considerable and ground-breaking medical progress to break through the glass ceiling of 115 years. Just ‘renovating the facade’, just using traditional medicine, will not be enough. The ‘rectangularisation of the death curve’ which was mentioned at the beginning of this article means that this progress will be useful to more and more citizens.


Good News of the Month: More and more public health data sharing for research purposes

On 16 April 16, 2018, the European Commission announced that 13 European countries have signed a declaration to allow cross-border access to their genomic information. This is a very important step in sharing genomic data useful for medical research.

In France, following a wide-ranging debate on the use of artificial intelligence, President Macron, presenting to the College of France a report entitled Giving meaning to artificial intelligence: a national and European strategy, announced the creation of a health data hub stating notably that We have a real advantage: we have a highly centralized health system with exceptionally rich databases. They are among the largest in the world and bring major scientific discoveries within our reach.

This realization by the public authorities in the European Union of the usefulness for medical research of pooling citizens’ data (while preserving anonymity) is a considerable step forward for medical research against senescence.


For more information :

 

 

Artificial intelligence for longevity. The death of death. March 2018. N° 108.

The first person to live to 200 years old has already been born. The future is enormous. It has never been more existentially transformative. Stephen Fry, British writer, comedian, actor and director, March 2018.


Topic of the month: How could artificial intelligence (weak or strong) help against aging ?


There are many definitions of artificial intelligence. In this paper, we will examine all of the computer applications capable of performing operations previously accessible only to humans. The term “strong” or “general” (but not necessarily conscious) artificial intelligence is used to refer to a computer system with an overall ability approaching or exceeding human ability.

There are currently countless computer applications with a specific intelligence exceeding humans in more and more numerous and broad fields, but no form of general artificial intelligence.

Reducing the risks of senescence can also help reduce other risks for humanity. 

The same is true for artificial intelligence as for many other technological advances. It can bring progress or it may bring human destruction.

But when it comes to artificial intelligence it gets worse, as in the case of a few other technological advances, such as nuclear energy. In the worst-case scenario it is not only lives of men and women that are at stake, but the fate of humanity as a whole. Scientists and major figures such as Elon Musk, Bill Gates and Stephen Hawking have raised questions about this issue. They were inspired, notably, by Nick Bostrom, a Swedish philosopher living in Oxford and author of the book Superintelligence, paths, dangers and strategies.

Nick Bostrom is not only pessimistic, or more precisely, extremely prudent, with regard to technological progress. He is also among those who think that we could one day vanquish illnesses linked to aging thanks to scientific progress. He expressed this idea, in an imaginative way, back in 2005, in his Fable of the Dragon-Tyrant.

Living longer and escaping from so-called ‘existential risks’ (which could end the history of humanity) make up two complementary fundamental concerns.

In this letter, we consider that prioritizing the use of artificial intelligence for everything that makes humans more resistant to disease and damage is a potentially positive endeavour for that objective and equally so as to reduce the risks of destruction.

Indeed, among the major characteristics of artificial intelligence, there is the fact that this intelligence is not​ necessarily:

  • combined with a moral sense considering human life to be a fundamental value;
  • endowed with ‘common sense’, that’s to say, the same lines of thought of which most normally informed humans would spontaneously be capable.

For example : it is ‘common sense’ that the best way to look after plants so that they do not die of thirst is not to destroy the plants, even if this will avoid them dying of thirst. Yet, this common sense is not necessarily obvious to a ‘super-intelligent’ machine.

A use of artificial intelligence centred on health should reduce the probability of catastrophic consequences arising, since the ultimate goal will be the long-term improvement of human well-being. This will require us to theorize in detail all that is good for the health, resilience and integrity of human beings and this could also ‘disaccustom’ us, discourage us, from potentially harmful research.

Artificial intelligence to accelerate product research (biological or not) and to automate experiments

The cost of sequencing is decreasing considerably, but still remains relatively high for those species that have not yet been ‘deciphered’. That is one of the reasons that many living species with very short or very long lifespans have not yet been sequenced.

Maximum lifespan among the millions of living species varies from a few days to several centuries and even several millennia for certain plants. Within a given species, the maximum lifespan also varies significantly. There is still much research to be done to understand the genes involved in senescence and their interactions and then to explore the biological reasons for these differences and possible gene therapies.

In addition, many substances and combinations of substances used in the medical field could have a favourable impact on longevity. IT tools allow us to detect what is most promising on the basis, notably, of an analysis of the scientific literature and of ‘automated’ projections from this analysis. That could be a field of exploration covered by IBM Watson, which currently works mainly on medical diagnosis. It is also one of the fields of investigation covered by the company Insilico Medicine.

In the laboratories themselves, a great deal of longevity research is carried out with animals (drosophila, flies,…). Computer and also robotic applications allow us to envisage an acceleration of data processing and reduction of costs, whether in terms of care of the animals or measurement of all the parameters. For example, for mice it should be possible to look after the animals and accurately measure certain metabolic modifications without human intervention (and also with less risk of error and subjectivity).

Finally, in the more distant future, it is conceivable that we may be able to introduce nanotechnology-sized tools into the human body that include a software application (or connected to a network).

Artificial intelligence to simulate animal research

Cells, neurons, organs and interactions between them can to a greater and greater extent be simulated with IT. This is useful from the point of view of cost, speed and also animal welfare. Currently, the most studied invertebrate in the animal world, the nematode C. Elegans is also the animal for which computer simulations are the most developed, particularly for the 302 neurons of its (tiny) nervous system.

Artificial intelligence to simulate research on humans

The same applies for humans as for the rest of the living world, as concerns the interest of simulation, but with greater complexity and interest.

There is no current project to simulate an entire human being, but there are many studies based on certain organs. In the neurological field, the most important current simulation work is that carried out by the European Human Brain Project (and the similar American project). It is about understanding the mechanism of the brain, including Alzheimer’s disease. As things stand, researchers are still very far from a representation neuron by neuron and synapse by synapse of the brain. The most complex organ in the known universe is not yet within the reach of the most advanced computer scientists.

And what we haven’t thought about yet

The progress of medicine, science and artificial intelligence will not stop at what we imagine today, whether dreams or nightmares. We will go beyond that.


Good news of the month: Three days of international conference to « undo » aging


On March 15, 16 and 17, hundreds of researchers, activists, journalists and investors from all over the world met in Berlin for the Undoing Aging conference. They explored together the mechanisms of human aging and ways to slow it down or even reverse it.

At the end of the conference, it was announced that the event would now be annual. It is to be hoped that this conference will only be necessary for a few years!


For more information:

La mort de la mort N°78 – Septembre 2015

Vivre beaucoup plus longtemps, plus d’ennui ou moins de stress ?

Notre espoir d’immortalité ne provient d’aucune religion, mais presque toutes les religions proviennent de cet espoir. Robert Green Ingersoll, Views on Politics and Religion. Chicago Times, 1879 (traduction)

Parmi les paradoxes de la société contemporaine, il y a celui du temps disponible: à la fois rare et abondant. Jamais, dans l’histoire de l’humanité, nous n’avons eu autant de temps libre. Cependant, beaucoup d’hommes et de femmes ressentent la vie contemporaine comme stressante et obligeant à se hâter.

Nous avons beaucoup plus de temps pour nous détendre parce que la durée du travail est plus courte et parce que les tâches ménagères sont beaucoup plus faciles à accomplir. Nous avons plus de temps également parce que la durée de notre vie est beaucoup plus longue.

Nous ressentons cependant une pression forte parce que l’éventail des activités que nous choisissons, des actes non nécessaires à notre survie, s’est élargi d’une manière qui était inimaginable il y a à peine un siècle.

Pour la majorité des citoyens de la planète, l’accès internet offre un choix de jeux, de films, de lectures, de musiques, d’activités virtuelles collectives ou individuelles qui est tellement large et rapidement renouvelé que nous n’en connaîtrons jamais qu’une partie négligeable Nos « amis » virtuels se multiplient et nous pouvons nous intégrer dans des communautés innombrables. D’autres loisirs sont plus accessibles qu’auparavant. En outre, pour environ deux milliards de citoyens (relativement) aisés, le monde est réellement accessible et il est possible financièrement de se déplacer physiquement presque d’un bout à l’autre des terres émergées.

Nous vivons donc plus la « civilisation des loisirs » que celle des « vacances » (issu du latin vacuum: vide). Les longues soirées d’hiver, d’ennui et d’uniformité, dans de froides chaumières ne sont plus qu’un souvenir qui devrait être assez désagréable, si notre mémoire n’était pas sélective.

Certains affirment, malgré l’abondance de choix contemporaine qu’une vie sans limitation de durée serait ennuyeuse. Nous ne profiterions des loisirs que parce qu’ils sont limités en durée. À cette affirmation, plusieurs contre-arguments peuvent être apportés:

– L’ennui apparaît aujourd’hui déjà chez des très jeunes adultes. D’ailleurs, les personnes plus âgées s’étonnent souvent que les adolescents soient désoeuvrés alors qu’ils ont tant de choses à faire. Autrement dit, ne pas s’ennuyer, c’est un apprentissage qui demande du temps. Les personnes âgées ressentent plutôt moins l’ennui,

– Dans le même ordre d’idées, l’ennui n’est pas plus souvent exprimé chez les personnes âgées de plus de 60 ou 65 ans que chez les autres adultes. Pourtant, les pensionnés n’ont (généralement) plus d’activités rémunérées. En fait, le malaise le plus exprimé vient des personnes plus jeunes en inoccupation forcée (les chômeurs).

– L’impression de lassitude ou de « désoeuvrement » peut être renforcée (ou diminuée) en fonction de la pression sociale à exercer ou non certaines activités. Les inactifs qui se percevront comme « aux crochets de la société » ressentiront un plus grand manque d’enthousiasme pour des activités « non poductives ».

L’argument le plus fréquemment entendu à propos des dangers supposés de la longévité est celui de l’ennui suite à la répétition, parce que nous aurions tout essayé… C’est certain que certaines occupations trop répétées sont lassantes. Mais il s’agit seulement de cas spécifiques. Une bonne partie de ces sentiments vient probablement de ce que nous surestimons l’importance de ce que d’autres possèdent, certains objets de luxe particulièrement. Une fois que nous en disposons à volonté, nous nous apercevons assez vite que ces biens ont surtout une plus-value symbolique et le plaisir de les posséder fait place à la lassitude.

Quant à l’idée que nous pourrons tout remettre à plus tard parce que nous aurons du temps sans limite, si c’était exact, nous devrions déjà aujourd’hui constater ce phénomène bien plus chez les jeunes que chez les personnes âgées. De plus, au fur et à mesure que la durée de vie s’allonge, le rythme de changement de la société s’accélère plutôt qu’il ne ralentit.

En fait, pour de nombreuses activités, c’est précisément une forme de répétition qui crée le plaisir. L’amitié, le sentiment de plénitude en se retrouvant chez soi après un voyage, le plaisir pris à participer à des jeux de société, l’attente agréable du début d’un feuilleton télévisé, naissent d’un mélange d’uniformité et de nouveauté. Nous n’allons pas dans notre restaurant ou notre espace vert favori parce qu’il est fort différent chaque fois, mais parce que nous apprécions une certaine uniformité

Enfin et peut-être surtout, l’ennui et le stress proviennent notamment de ce que nous sommes conscients que notre temps est compté. pour paraphraser Woody Allen, l’être humain ne sera pleinement tranquille que lorsqu’il ne mourra plus (de vieillesse)

Ceci ne signifie pas, si demain nous trouvons un moyen de vivre sans limitation de durée que tout se fera naturellement. Certains pourront choisir de continuer à vieillir. Il faudra un apprentissage « de tout ce temps ». Mais nous aurons le temps de nous y préparer!

La bonne nouvelle du mois: Les Nations-Unies se prononcent en faveur d’une vie en bonne santé à tous les âges

Les 28 et 29 septembre, en prolongement des objectifs du millénaire, l’ONU a formellement adopté 17 objectifs de développement durable. Le troisième de ces objectifs est intitulé « Santé » et il mentionne:

Donner les moyens de vivre une vie saine et promouvoir le bien-être de tous à tous les âges est essentiel pour le développement durable. Des progrès sensibles ont été accomplis dans l’accroissement de l’espérance de vie et la réduction de certaines causes majeures de la mortalité infantile et maternelle. Des progrès notables ont été accomplis dans l’amélioration de l’accès à l’eau salubre et à l’assainissement, la réduction du paludisme, de la tuberculose, de la poliomyélite de la propagation du VIH/sida. Toutefois, il faut faire beaucoup plus pour éradiquer un large éventail de maladies et s’occuper de nombreuses questions de santé fort différentes, persistantes ou nouvelles.

Dans un monde où environ 70 % des décès sont dûs aux maladies liées au vieillissement, c’est bien sûr en luttant contre ces affections et contre le mécanisme de vieillissement en général que les progrès les plus importants peuvent être accomplis.

Pour en savoir plus:

De manière générale, voir notamment: heales.org, sens.org et longecity.org
À propos de l’objectif des Nations-Unies en matière de santé: www.un.org/sustainabledevelopment/fr/health
Source de la peinture (Symposium, Galena, 1896): en.wikipedia.org/wiki/Mal_du_siècle/media/File:Gallen_Kallela_Symposion.jpg